Arcus Biosciences (RCUS) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Arcus Biosciences (RCUS) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Arcus Biosciences

· RCUS

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

3.266 B

-2.32%

General

Market Cap: $3.27B
Enterprise Value: $3.14B
Shares Outstanding: 125,770,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 94.02%
Operating Margin: -415.38%
Net Profit Margin: -386.32%
FCF Margin: -405.98%
ROA: -48.92%
ROE: -87.98%
ROIC: -65.76%
Current Ratio: 3.82
Debt-to-Equity: 0.25
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.29
P/S: 27.12
P/FCF: —
P/B: 6.84
EV/EBITDA: -7.49

Growth

Rev 1Y: -4.26%
Rev 1Y Fwd Est: -68.17%
Rev 3Y (CAGR): 30.16%
Rev 5Y (CAGR): 25.93%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $117M
Gross Margin: 94.02%
Operating Expenses: $596M
Operating Income: -$486M
Net Profit: -$452M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $150M
Working Capital: $558M
Total Assets: $924M
Net Debt: -$36M
Total Liabilities: $460M
Total Equity: $464M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$474M
Cash Flow from Investing: $63M
Cash Flow from Financing: $313M
Free Cash Flow: -$475M
Capital Expenditures: $1M